Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
20/20 Biolabs Inc. (AIDX) had Income from Continuous Operations of -3.74M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-3.74M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Income from Continuous Operations |
-3.74M |
-3.74M |
|
-- |
|
-- |
|
-- |
|
4.92M |
|
4.92M |
|
-0.76 |
|
-0.76 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|